Singapore: A recent report by Research and Markets estimates that global mHealth apps market will reach $6.6 billion in ...
Singapore: Elsevier and the Australasian Research Management Society (ARMS) awarded the winners of the 3rd annual Scopu...
Singapore: Merck, a leading company for innovative and top-quality high-tech products in healthcare, lifescience and per...
Singapore: In a bid to launch overseas and to expand its Australian operations, Brisbane-based personalised medicine sta...
Singapore: Scientists at James Cook University (JCU) in Townsville, Queensland, Australia, used sunlight to convert a de...
A doctor by training, Dr Brian A McNamee was enjoying himself in various job roles starting out as product manager, a jo...
Singapore: Bionomics, a biopharmaceutical company, has filed a patent application for BNC105 in combination with immune ...
Singapore: Agilent Technologies plans to collaborate with the University of Queensland Center for Clinical Research in B...
Singapore: Australia-based Cellmid plans to acquire Japanese firm Advangen that owns the FGF-5 inhibitor hair growth tec...
Singapore: Australia life science association, AusBiotech, has proposed to develop an investor incentive model to stimul...
Australia-based Telezon Limited's CoreIT and SoloFlow Reconstitution Needle technology have already made a mark for itse...
Singapore: Australian drug development company Invion has partnered with Hovione Scientia, an international pharmaceutic...
Singapore: Universal Biosensors has strengthened its partnership with Siemens Healthcare Diagnostics, by signing a long...
Singapore: Prana Biotechnology announced that the Journal of Huntington's Disease, has in its December 2012 edition, ...
Singapore: Australia based ResMed plans to acquire China and US based Curative Medical, provider of non-invasive ventila...
Singapore: Bionomics has identified a novel compound with promising properties as a potential new treatment for Alzheim...
Singapore: Australia's New South Wales government has recently announced that it would spend nearly $1.7 million on a me...
Singapore: Australia-based Medvet science has licensed a cell line from ACTYE biotech to manufacture its monoclonal canc...
